The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia

Author:

Ardeljan Daniel12,Taylor Martin S3,Ting David T4,Burns Kathleen H15

Affiliation:

1. McKusick-Nathans Institute of Genetic Medicine (IGM) and

2. Medical Scientist Training Program (MSTP), Johns Hopkins University School of Medicine, Baltimore, MD

3. Department of Pathology, Massachusetts General Hospital, Boston, MA

4. Department of Medicine and the Massachusetts General Hospital Cancer Center, Boston, MA

5. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

Abstract

Abstract BACKGROUND A large portion of intronic and intergenic space in our genome consists of repeated sequences. One of the most prevalent is the long interspersed element-1 (LINE-1, L1) mobile DNA. LINE-1 is rightly receiving increasing interest as a cancer biomarker. CONTENT Intact LINE-1 elements are self-propagating. They code for RNA and proteins that function to make more copies of the genomic element. Our current understanding is that this process is repressed in most normal cells, but that LINE-1 expression is a hallmark of many types of malignancy. Here, we will consider features of cancer cells when cellular defense mechanisms repressing LINE-1 go awry. We will review evidence that genomic LINE-1 methylation, LINE-1–encoded RNAs, and LINE-1 ORF1p (open reading frame 1 protein) may be useful in cancer diagnosis. SUMMARY The repetitive and variable nature of LINE-1 DNA sequences poses unique challenges to studying them, but recent advances in reagents and next generation sequencing present opportunities to characterize LINE-1 expression and activity in cancers and to identify clinical applications.

Funder

Affymetrix, Inc.

Burroughs Wellcome Fund

Warshaw Institute for Pancreatic Cancer Research

Verville Family Pancreatic Cancer Research Fund

National Institute of General Medical Sciences

Systems Biology of Retrotransposition NIGMS

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3